Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

seekingalpha.com / Share Newsitem

View, share or embed this newsitem using the details below.
Traws Pharma (TRAW) stock rocketed 260% after the company announced progress in developing its influenza treatment tivoxavir marboxil for the treatment of H5N1 bird flu.
Continue
Please wait ...